Women's imaging vendor Fischer Imaging reported first-quarter revenues of $14.4 million, up 20% compared with the $12 million posted in the same period last year.
For the quarter (end-March 31), the Denver-based firm had a net loss of $6.6 million, compared with a net loss of $4.5 million a year ago. The net loss included other financing expenses and interest expenses of $2.8 million associated with a loan from ComVest Capital Partners II.
Fischer president and CEO Harris Ravine said that while the firm has made progress in its RE&S (radiology, electrophysiology, and surgery imaging) and stereotactic biopsy lines, the delay in launching the new version of its SenoScan system, combined with increasingly competitive pricing pressures, will continue to put pressure on Fischer's growth and will impact profitability. Facing liquidity constraints, Fischer is taking steps to reduce expenses and investigate strategic alternatives, Ravine said.
By AuntMinnie.com staff writers
May 23, 2005
Related Reading
Fischer late with 10-Q report, May 17, 2005
Fischer's 2004 net loss narrows on higher sales, April 1, 2005
Fischer nets SenoScan installs, December 9, 2004
Fischer cleared for interstitial breast brachytherapy, December 2, 2004
Fischer grows revenues, settles with SEC, November 16, 2004
Copyright © 2005 AuntMinnie.com
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&fit=crop&h=100&q=70&w=100)
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
